With a New Year come new hopes ! OphtAI wishes you a wonderful Year 2022 ! We are currently setting the stage for great things right now. Follow us to stay tuned !
OPHTAI WAS INVOLVED IN A LARGE TELERETINAL SCREENING PROGRAM ORGANIZED BY UNIVERSITY OF WASHINGTON TO ASSESS DIABETIC RETINOPATHY ON 23,724 PATIENTS AT HOSPITALS IN SEATTLE AND ATLANTA On January 7, 2021, Aaron Lee’s article in the ADA Diabetes Care was...
OphtAI is very proud to be one of the 5 AI solutions selected for a real world validation study performed by Pr. Aaron Lee and published in the prestigious ADA Diabetes Care Journal. The OphtAI solution is one of the two solutions deemed to be usable in all...
World Health Organizationâs recent study, âworld report on vision 2019â revealed that population growth and ageingâalong with lifestyle changes and urbanizationâwill âdramatically increaseâ the number of people with eye conditions, vision impairment, and blindness in...
OphtAI will be a partner of the next SFO e-congress to be held on September 4 and 5, 2020. At the start of the new school year, we look forward to seeing you again and on SFO online. Relive the highlights of OphtAI at SFO 2019 with exclusive testimonials from the: Pr...
Recent Comments